麻豆学生精品版

Cindy B. Matsen
( out of 91 reviews )

Cindy B. Matsen, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital North

2K, Gynecology and Mammography
Salt Lake City
801-213-4269

Sugar House Health Center

Salt Lake City
801-581-2000

  • Cindy B. Matsen is a fellowship trained breast surgeon at the University of Utah, Huntsman Cancer Institute. She is board certified in General Surgery and is an Associate Professor in the Department of Surgery and specializes in the surgical treatment of breast cancer and benign breast diseases. She received her undergraduate degree from the University of Oregon and her MD from the University of Chicago Pritzker School of Medicine. She then completed a residency in General Surgery at the University of Utah and a fellowship in Breast Surgical Oncology at Memorial Sloan Kettering Cancer Center in New York City. She has special interests in young breast cancer patients, doctor-patient communication, patient education, and decision making. She has research interests in shared decision making, health communication, and cancer care delivery. Her works focuses on better understanding how shared decision making is viewed and implemented by providers and designing interventions to improve the shared decision making process. She is particularly interested in preference elicitation and how better training of providers in preference elicitation techniques can improve cancer outcomes. She enjoys collaborative work and has ongoing collaborations with researchers in communication, population health, epidemiology, engineering, and molecular biology. Her overall goal is to improve our ability to provide patient-centered care for cancer patients.

    Specialties

    Board Certification

    American Board of Surgery (Sub: General Surgery)

    Patient Rating

    5.0 /5
    ( out of 91 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 29, 2024
    HUNTSMAN CANCER CENTER

    Dr. Matsen is knowledgeable and interested in what she does. I can tell she puts thought into my treatment. She is also positive and encouraging to talk to.

    October 29, 2024
    SUGAR HOUSE HEALTH CENTER

    She is very knowledgeable. She really listens to concerns and gives feedback that is understandable. As a patient I feel like my voice is heard.

    October 19, 2024
    HUNTSMAN CANCER CENTER

    Dr Matsen was great. She explained things in detail, in a way that I could understand. She listened carefully to me, and took care when she examined me not to cause pain. I would highly recommend her.

    October 07, 2024
    HUNTSMAN CANCER CENTER

    Dr. Matsen is the best. She's smart, knowledgable, kind and warm. I absolutely trust her to give me the best advice.

    September 21, 2024
    HUNTSMAN CANCER CENTER

    My hope is that every cancer patient has a doctor who is as knowledgeable, kind, compassionate, and respectful as Cindy Matsen. She is an amazing doctor, and a wonderful person.

    September 11, 2024
    HUNTSMAN CANCER CENTER

    Dr Matsen is always wonderful!! She's so patient, thorough & I never feel rushed. I can't say enough wonderful things about her!

    September 08, 2024
    SUGAR HOUSE HEALTH CENTER

    Dr. Matsen is a great doctor? She listens & explains everything very well?

    July 21, 2024
    SUGAR HOUSE HEALTH CENTER

    Always the most professional of care and personable.

    July 20, 2024
    HUNTSMAN CANCER CENTER

    Dr. Matsen took the time to explain all the options and was part of the decision on the course of action.

    See More Patient Comments

  • Cindy B. Matsen is a fellowship trained breast surgeon at the University of Utah, Huntsman Cancer Institute. She is board certified in General Surgery and is an Associate Professor in the Department of Surgery and specializes in the surgical treatment of breast cancer and benign breast diseases. She received her undergraduate degree from the University of Oregon and her MD from the University of Chicago Pritzker School of Medicine. She then completed a residency in General Surgery at the University of Utah and a fellowship in Breast Surgical Oncology at Memorial Sloan Kettering Cancer Center in New York City. She has special interests in young breast cancer patients, doctor-patient communication, patient education, and decision making. She has research interests in shared decision making, health communication, and cancer care delivery. Her works focuses on better understanding how shared decision making is viewed and implemented by providers and designing interventions to improve the shared decision making process. She is particularly interested in preference elicitation and how better training of providers in preference elicitation techniques can improve cancer outcomes. She enjoys collaborative work and has ongoing collaborations with researchers in communication, population health, epidemiology, engineering, and molecular biology. Her overall goal is to improve our ability to provide patient-centered care for cancer patients.

    Board Certification and Academic Information

    Academic Departments Surgery -Primary
    Academic Divisions Surgical Oncology
    Board Certification
    American Board of Surgery (Sub: General Surgery)

    Education history

    Graduate Training Health Services Research - University of Utah M.S.C.I
    Breast Surgical Oncology - Memorial Sloan-Kettering Cancer Center Fellow
    Residency General Surgery - University of Utah Affiliated Hospitals Resident
    Medicine - University of Chicago Pritzker School of Medicine M.D.
    Undergraduate Biology - University of Oregon B.S.

    Selected Publications

    Journal Article

    1. Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle T, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA (2024). ASO Visual Abstract: Clipping the Positive Lymph Node in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Ann Surg Oncol. ()
    2. Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle TM, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA (2024). Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Ann Surg Oncol. ()
    3. Vaklavas C, Matsen CB, Chu Z, Boucher KM, Scherer SD, Pathi S, Beck A, Brownson KE, Buys SS, Chittoria N, DAstous E, Gulbahce HE, Henry NL, Kimani S, Porretta J, Rosenthal R, Ward J, Wei M, Welm BE, Welm AL (2024). TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast Cancer. JCO Precis Oncol, 8, e2300724. ()
    4. Amann ES, Ose J, Hathaway CA, Oswald LB, Hardikar S, Himbert C, Chellam V, Lin T, Daniels B, Kirchhoff AC, Gigic B, Grossman D, Tward J, Varghese TK Jr, Shibata D, Figueiredo JC, Toriola AT, Beck A, Scaife C, Barnes CA, Matsen C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Grady WM, Schneider M, Dinkel A, Islam JY, Gonzalez BD, Otto AK, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR (2024). Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic. J Behav Med, 47(3), 405-421. ()
    5. King AJ, Dunbar NM, Margolin D, Chunara R, Tong C, Jih-Vieira L, Matsen CB, Niederdeppe J (2023). Global prevalence and content of information about alcohol use as a cancer risk factor on Twitter. Prev Med, 177, 107728. ()
    6. Covington MF, Hoffman JM, Morton KA, Buckway B, Boucher KM, Rosenthal R, Porretta J, Brownson KE, Matsen CB, Vaklavas C, Ward JH, Wei M, Buys SS, Chittoria N, Yakish ED, Archibald ZG, Burrell LD, Butterfield RI, Yap JT (2023). Prospective Pilot Study of (18)F-Fluoroestradiol PET/CT in Patients With Invasive Lobular Carcinomas. AJR Am J Roentgenol, 221(2), 228-239. ()
    7. Erickson JR, Pahlkotter MK, Thielking PD, Porretta JM, Rosenthal R, Matsen CB, Brownson KE (2023). Leveraging telehealth supportive oncology services to combat COVID-19 isolation in breast cancer patients: A cancer center鈥檚 perspective. Patient Exp J, 10(2), 133-137. ()
    8. Morris BB, Smith JP, Zhang Q, Jiang Z, Hampton OA, Churchman ML, Arnold SM, Owen DH, Gray JE, Dillon PM, Soliman HH, Stover DG, Colman H, Chakravarti A, Shain KH, Silva AS, Villano JL, Vogelbaum MA, Borges VF, Akerley WL, Gentzler RD, Hall RD, Matsen CB, Ulrich CM, Post AR, Nix DA, Singer EA, Larner JM, Stukenberg PT, Jones DR, Mayo MW (2022). Replicative Instability Drives Cancer Progression. Biomolecules, 12(11). ()
    9. Teller P, Nguyen TT, Tseng J, Allen L, Matsen CB, Bellavance E, Kaufman D, Hieken T, Nagel S, Patten C, Pomerenke L, Tevis SE, Sarantou T (2022). Innovation in Breast Surgery: Practical and Ethical Considerations. Ann Surg Oncol, 29(10), 6144-6150. ()
    10. Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR (2022). Factors associated with changes in exercise behaviors during the COVID-19 pandemic. Cancer Causes Control, 33(7), 939-950. ()
    11. Goodwin IA, Luo J, Magno-Pardon DA, Veith J, Willcockson J, Carter G, Matsen C, Kwok AC, Agarwal CA (2022). Current Practices in the Pathologic Assessment of Breast Tissue in Transmasculine Chest Surgery. Plast Reconstr Surg, 150(3), 516e-525e. ()
    12. Peoples AR, Oswald LB, Ose J, Daniels B, Himbert C, Hathaway CA, Gigic B, Kirchhoff AC, Lin T, Grossman D, Tward J, Varghese TK Jr, Figueiredo JC, Toriola AT, Beck A, Scaife C, Shibata D, LaStayo P, Gonzalez B, Salas K, Ashworth A, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM (2022). Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions. J Rural Health, 38(4), 886-899. ()
    13. Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, DeRose YS, Zhao L, Cortes-Sanchez E, Yang CH, Toner J, Wang G, Qiao Y, Huang X, Greenland JA, Vahrenkamp JM, Lum DH, Factor RE, Nelson EW, Matsen CB, Poretta JM, Rosenthal R, Beck AC, Buys SS, Vaklavas C, Ward JH, Jensen RL, Jones KB, Li Z, Oesterreich S, Dobrolecki LE, Pathi SS, Woo XY, Berrett KC, Wadsworth ME, Chuang JH, Lewis MT, Marth GT, Gertz J, Varley KE, Welm BE, Welm AL (2022). A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nat Cancer, 3(2), 232-250. ()
    14. Jimenez RB, Johnson AE, Horick NK, Hlubocky FJ, Lei Y, Matsen CB, Mayer EL, Collyar DE, LeBlanc TW, Donelan K, Mello MM, Peppercorn JM (2021). Do you mind if I record?: Perceptions and practice regarding patient requests to record clinic visits in oncology. Cancer, 128(2), 275-283. ()
    15. Walker HR, Evans E, Nirula R, Hyngstrom J, Matsen C, Nelson E, Pickron B, Zurbuchen E, Morrow EH (2021). "I need to have a fulfilling job": A qualitative study of surgeon well-being and professional fulfillment. Am J Surg, 223(1), 6-11. ()
    16. Serpico VJ, Mone MC, Zhang C, Presson AP, Killian H, Agarwal J, Matsen CB, Porretta J, Nelson EW, Junkins S (2021). Preoperative multimodal protocol reduced postoperative nausea and vomiting in patients undergoing mastectomy with reconstruction. J Plast Reconstr Aesthet Surg, 75(2), 528-535. ()
    17. Agarwal S, Pappas L, Matsen CB, Agarwal JP (2020). Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy. Cancer Med, 9(21), 8043-8052. ()
    18. Gutnik L, Allen CM, Presson AP, Matsen CB (2020). Breast Cancer Surgery Decision Role Perceptions and Choice of Surgery. Ann Surg Oncol, 27(10), 3623-3632. ()
    19. Serpico V, Mone M, Zhang C, Presson A, Matsen C, Junkins S, Killian H, Porretta J, Agarwal J, Nelson E (2020). Standard preoperative use of nonopioid multi-modal medications for patients undergoing mastectomy with immediate reconstruction and the effect on postoperative opioid needs. Breast J, 26(5), 966-970. ()
    20. Matsen CB, Ray D, Kaphingst KA, Zhang C, Presson AP, Finlayson SRG (2019). Patient Satisfaction With Decision Making Does Not Correlate With Patient Centeredness of Surgeons. J Surg Res, 246, 411-418. ()
    21. Taylor MA, Allen CM, Presson AP, Millar MM, Zurbuchen R, Matsen CB (2019). Exploring Surgeon Variability in Recommendations for Contralateral Prophylactic Mastectomy: What Matters Most? Ann Surg Oncol, 26(10), 3224-3231. ()
    22. Albright FS, Kohlmann W, Neumayer L, Buys SS, Matsen CB, Kaphingst KA, Cannon-Albright LA (2019). Population-based relative risks for specific family history constellations of breast cancer. Cancer Causes Control, 30(6), 581-590. ()
    23. Garlick JW, Olson KA, Downs-Kelly E, Bucher BT, Matsen CB (2018). Secretory breast carcinoma in an 8-year-old girl: A case report and literature review. Breast J, 24(6), 1055-1061. ()
    24. Kaphingst KA, Ivanovich J, Lyons S, Biesecker B, Dresser R, Elrick A, Matsen C, Goodman M (2018). Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors. Transl Behav Med, 8(1), 71-79. ()
    25. Frandsen JE, Cannon G, Kokeny KE, Gaffney DK, Matsen C, Wright M, Poppe MM (2017). Is radiation indicated for young women with early stage, node-negative breast cancer after mastectomy? A multi-institution, retrospective review. Breast J, 24(1), 7-11. ()
    26. Carmichael H, Matsen C, Freer P, Kohlmann W, Stein M, Buys SS, Colonna S (2017). Breast cancer screening of pregnant and breastfeeding women with BRCA mutations. Breast Cancer Res Treat, 162(2), 225-230. ()
    27. Cohen AL, Factor RE, Mooney K, Salama ME, Wade M, Serpico V, Ostrander E, Nelson E, Porretta J, Matsen C, Bernard P, Boucher K, Neumayer L (2017). POWERPIINC (PreOperative Window of Endocrine TheRapy Provides Information to Increase Compliance) trial: Changes in tumor proliferation index and quality of life with 7 days of preoperative tamoxifen. Breast, 31, 219-223. ()
    28. Kaphingst KA, Ivanovich J, Elrick A, Dresser R, Matsen C, Goodman MS (2016). How, who, and when: preferences for delivery of genome sequencing results among women diagnosed with breast cancer at a young age. Mol Genet Genomic Med, 4(6), 684-695. ()
    29. Matsen C, Villegas K, Eaton A, Stempel M, Manning A, Cody HS, Morrow M, Heerdt A (2016). Late Axillary Recurrence After Negative Sentinel Lymph Node Biopsy is Uncommon. Ann Surg Oncol, 23(8), 2456-61. ()
    30. Ugras S, Matsen C, Eaton A, Stempel M, Morrow M, Cody HS 3rd (2016). Reoperative Sentinel Lymph Node Biopsy is Feasible for Locally Recurrent Breast Cancer, But is it Worthwhile? Ann Surg Oncol, 23(3), 744-8. ()
    31. Matsen CB, Mehrara B, Eaton A, Capko D, Berg A, Stempel M, Van Zee KJ, Pusic A, King TA, Cody HS 3rd, Pilewskie M, Cordeiro P, Sclafani L, Plitas G, Gemignani ML, Disa J, El-Tamer M, Morrow M (2016). Skin Flap Necrosis After Mastectomy With Reconstruction: A Prospective Study. Ann Surg Oncol, 23(1), 257-64. ()
    32. Frandsen J, Ly D, Cannon G, Suneja G, Matsen C, Gaffney DK, Wright M, Kokeny KE, Poppe MM (2015). In the Modern Treatment Era, Is Breast Conservation Equivalent to Mastectomy in Women Younger Than 40 Years of Age? A Multi-Institution Study. Int J Radiat Oncol Biol Phys, 93(5), 1096-103.
    33. Bowen M, Matsen C (2015). Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 trial (CALGB 150007/150012; ACRIN 6657): Cureton EL, Yau C, Alvarado MD, et al (Univ of California San Francisco; Et al) Ann Surg Oncol 21:2889-2896, 2014. J Med Device, 26(1), 63-65. ()
    34. Matsen CB (2015). Regional lymphatic recurrence after salvage surgery for ipsilateral breast tumor recurrence of breast cancer without local treatment for regional lymphatic basin: Ishitobi M, Matsushita A, Nakayama T, et al (Osaka Med Ctr for Cancer and Cardiovascular Diseases, Japan) J Surg Oncol 110:265-269, 2014. J Med Device, 26(2), 147-149. ()
    35. Poruk KE, Ying J, Chidester JR, Olson JR, Matsen CB, Neumayer L, Agarwal J (2015). Breast cancer recurrence after nipple-sparing mastectomy: one institution's experience. Am J Surg, 209(1), 212-7. ()
    36. Matsen CB, Hirsch A, Eaton A, Stempel M, Heerdt A, Van Zee KJ, Cody HS 3rd, Morrow M, Plitas G (2014). Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases. Ann Surg Oncol, 21(10), 3330-5. ()
    37. Gligorich KM, Vaden RM, Shelton DN, Wang G, Matsen CB, Looper RE, Sigman MS, Welm BE (2013). Development of a screen to identify selective small molecules active against patient-derived metastatic and chemoresistant breast cancer cells. Breast Cancer Res, 15(4), R58. ()
    38. Lum DH, Matsen C, Welm AL, Welm BE (2012). Overview of human primary tumorgraft models: comparisons with traditional oncology preclinical models and the clinical relevance and utility of primary tumorgrafts in basic and translational oncology research. Curr Protoc Pharmacol, Chapter 14, Unit 14.22. ()
    39. Matsen CB, Luther SL, Stewart AK, Henderson WG, Kim H, Neumayer LA (2012). A match made in heaven? Trying to combine ACS-NSQIP and NCDB databases. J Surg Res, 175(1), 6-11. ()
    40. DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MT, Factor R, Matsen C, Milash BA, Nelson E, Neumayer L, Randall RL, Stijleman IJ, Welm BE, Welm AL (2011). Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med, 17(11), 1514-20. ()

    Review

    1. Singh P, Agnese D, Amin M, Barrio AV, Botty Van den Bruele A, Burke E, Danforth DN, Dirbas FM, Eladoumikdachi F, Kantor O, Kumar S, Lee MC, Matsen C, Nguyen TT, Ozmen T, Park KU, Plichta JK, Reyna C, Showalter SL, Styblo T, Tranakas N, Weiss A, Laronga C, Boughey J (2024). Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks. [Review]. Ann Surg Oncol, 31(4), 2212-2223. ()
    2. Matsen C, Van Zee KJ (03/2014). Use of Established Nomograms to Predict Non-Sentinel Lymph Node Metastasis. [Review]. Curr Breast Cancer Rep, 6(1).
    3. Matsen CB, Neumayer LA (2013). Breast cancer: a review for the general surgeon. [Review]. JAMA Surg, 148(10), 971-9. ()

    Book Chapter

    1. Matsen C, Neumayer L (2012). Hernia. In Matsen C|Neumayer L (Ed.), J Med Device (pp. 919-924). ()

    Commentary

    1. Matsen CB, Neumayer LA (2016). Commentary on Pilewskie M, Jochelson M, Gooch J et al. 鈥淚s Preoperative Axillary Imaging beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Dissection?鈥 J Am Coll Surg. 2016 Feb;222(2):138-45.
    2. Matsen CB (2016). Commentary on Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy: Swisher SK, Vila J, Tucker SL, et聽al (The Univ of Texas MD Anderson Cancer Ctr, Houston) Ann Surg Oncol 23:749-756, 2016. 27(4), 306-307.
    3. Weitz A, Matsen CB (2016). Commentary on Differences in Response and Surgical management with neoadjuvant chemotherapy in invasive lobular vs ductal breast cancer. Truin W, Vugts G,, Roumen RM, et al. Ann Surg Oncol. 2016 Jan;23(1):51-7. 27(3), 222-224.
    4. Matsen CB (2016). Commentary on Regional Lymphatic Recurrence After Salvage Surgery for Ipsilateral Breast Tumor Recurrence of Breast Cancer Without Local Treatment for Regional Lymphatic Basin. 26(2).
    5. Bowen M and Matsen CB (April-June 2015). Commentary on Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012;ACRIN 6657). 26(1), 63-65.

    Case Report

    1. Maglic D, Moss W, Pires G, Agarwal A, Matsen C, Kwok A (2021). A Case Report of Misdiagnosed Breast Implant-associated Anaplastic Large Cell Lymphoma with Lymphatic Extension. Plast Reconstr Surg Glob Open, 9(11), e3916. ()

    Other

    1. Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR (2021). Impact of the COVID-19 pandemic on exercise habits among聽cancer patients. United States. ()

    Video/Film/CD/Web/Podcast

    1. Matsen (January 2023). Got your regular mammogram? Here's when you might want an extra checkup - Studio 5 - KSL.com, January 5, 2023   https://studio5.ksl.com/got-regular-mammogram-extra-checkup/   [Video].
    2. Cindy B Matsen (2015). Introduction to the Huntsman Cancer Institute's Breast Cancer Clinic [Video]. Available: https://www.youtube.com/watch?v=3ZAMUx5wDSg.
    3. Cindy B Matsen (2015). What to Expect After Surgery [Video]. Available: https://www.youtube.com/watch?v=0YGH0MnN644.
    4. Cindy B Matsen (2015). Surgery for Breast Cancer [Video]. Available: https://www.youtube.com/watch?v=ZKtCgNBcY5c.
    5. Cindy B Matsen (2015). What We Need to Know to Treat Your Breast Cancer [Video]. Available: https://www.youtube.com/watch?v=0w1P8WLiWnY.

    Patent

    1. Matsen CB (2012). Zebularine as an Inhibitor of DNA Methylation. U.S. Patent No. 8207142B2. Washington, D.C.:U.S. Patent and Trademark Office.

  • News & Podcasts

    Huntsman Cancer Institute News

    Podcasts